Designing malaria vaccines to circumvent antigen variability - Wikidata - wikimedia - TriplyDB

Designing malaria vaccines to circumvent antigen variability

Designing malaria vaccines to circumvent antigen variability

http://www.wikidata.org/entity/Q36514853

about

Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers.Immunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand PfRon2 Does Not Improve the In Vitro Efficacy.A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens.A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP142 in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage Challenge Mother-Newborn Pairs in Malawi Have Similar Antibody Repertoires to Diverse Malaria Antigens.Comparative analysis of low complexity regions in Plasmodia.High Level of Specific Anti-Plasmodium Falciparum Merozoite IgG1 Antibodies in Rural Asymptomatic Individuals of Dienga, South-Eastern Gabon.Disease burden and the role of pharmacogenomics in African populations.

P2860

Q30403003-55E3C4ED-94C9-4638-ACF3-B962CFDAD9AF Q33835382-74045659-AFFC-4806-93AB-876A7593CD2A Q36141540-94B8D84B-8B2F-4E98-8DB8-74EE9B9B75BA Q39315273-2C0E5CAA-A185-4F43-9EF7-A5097DF5ACF6 Q40082124-6605EE61-66F6-4C15-8B71-C5354000E214 Q48043737-676D9728-FE75-481F-B38C-D6E15056F1C6 Q49220322-7F12386D-CB43-42FA-8616-E59CA3A74D7D Q54935902-8500AAEA-B653-45AF-B2B3-83AEA83DB2B0

P2860

Designing malaria vaccines to circumvent antigen variability

http://www.wikidata.org/entity/Q36514853

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Designing malaria vaccines to circumvent antigen variability

@ast

Designing malaria vaccines to circumvent antigen variability

@en

type

label

Designing malaria vaccines to circumvent antigen variability

@ast

Designing malaria vaccines to circumvent antigen variability

@en

prefLabel

Designing malaria vaccines to circumvent antigen variability

@ast

Designing malaria vaccines to circumvent antigen variability

@en

P1433

Q36514853-868D047C-868F-4424-8651-A30F17E0FA5E

P1476

Q36514853-F1AC8F68-EFE9-445B-B697-EF1F640C3B9E

P2093

Q36514853-015D3FAC-BC9C-45C6-B71F-442D852571E7

Q36514853-1355B839-3403-4E14-8272-731403B2717D

Q36514853-5A037256-EF35-4AE7-93E3-C085DF7E267B

Q36514853-EB1C98AF-A1E1-4680-B447-039D193060B4

P275

Q36514853-575CBB8E-A39D-4A50-B973-F42A5FC384C4

P2860

Q36514853-033A85C0-6807-49DE-BBDB-699CB0E99E96

Q36514853-036D8336-ED63-40AB-AA42-4E07DB89794C

Q36514853-04B72BEC-5525-4988-937C-1D4B8D0698D9

Q36514853-057EA38E-E9D5-49BC-95A6-B3B415F21597

Q36514853-07F1F306-FB44-429B-848E-68EC910EDD2B

Q36514853-09B519B7-8A68-433D-8F7C-B623634642E8

Q36514853-1738495F-BBE5-4634-A0E6-3945C08AAA3A

Q36514853-1F72D851-F5A6-4E54-9960-FDBC801821E5

Q36514853-21CC802F-B1A2-496F-84A8-C254D067D171

Q36514853-290F9ACE-97DD-44D9-8F69-DD7961FA26DB

P304

Q36514853-68354049-85DF-47BB-9192-D0A5EBB48F28

P31

Q36514853-72056C5B-4F03-4E16-8C1C-0C0AB8BC7DDE

Q36514853-D8C5B286-7091-4BF8-AB3C-FD1AD009CDD0

P356

Q36514853-44E484A1-9856-41D4-9C57-42394CD0DECA

P407

Q36514853-DDFA3196-CA61-45FD-A932-4C61D4F064F9

P433

Q36514853-70308B82-3D9E-4E1A-9790-947D19D5AD8A

P478

Q36514853-2B1333A1-ECD9-4384-B8A5-5EE5D665CAB6

P50

Q36514853-21DF0BB2-9E6A-4D7D-A172-22DDD810FB14

Q36514853-A93D0B05-932D-45D2-98F6-DA0DD1AD7AA7

P5008

Q36514853-09120C22-669B-4E2E-9C8C-0EB2EBFF2802

P577

Q36514853-5C218F24-9854-4890-A8B4-2933036E6FE4

Q36514853-CEB334DD-F64E-4FE5-A046-61198BEE82D4

P5875

Q36514853-BDD58B55-3470-4674-A775-9FDF9DACF96E

P698

Q36514853-E12CD508-63A0-4F83-89A7-33097E1F940E

P921

Q36514853-8659DD70-6C17-4D6C-899B-4EF7462122C0

Q36514853-8782F29E-00E1-42F7-A120-C5BD4A13F592

P932

Q36514853-CF7D9771-7374-4F81-92C7-022002CB74AF

P356

J.VACCINE.2015.09.110

P1433

P1476

Designing malaria vaccines to circumvent antigen variability

@en

P2093

Alyssa E Barry

http://www.w3.org/2001/XMLSchema#string

Amed Ouattara

http://www.w3.org/2001/XMLSchema#string

Edmond J Remarque

http://www.w3.org/2001/XMLSchema#string

Sheetij Dutta

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Plasmodium falciparum erythrocyte invasion: combining function with immune evasion

Vaccines for malaria: how close are we?

Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

Mapping the antigenic and genetic evolution of influenza virus

Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation.

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.

Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.

RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection.

Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.

P304

7506-7512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2015.09.110

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Christopher V Plowe

P5008

P577

2015-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282944388

http://www.w3.org/2001/XMLSchema#string

P698

26475447

http://www.w3.org/2001/XMLSchema#string

P921

genetic variation

P932

4731100

http://www.w3.org/2001/XMLSchema#string